Logo image of GH

GUARDANT HEALTH INC (GH) Stock Analyst Ratings

NASDAQ:GH - Nasdaq - US40131M1099 - Common Stock - Currency: USD

43.84  -0.21 (-0.48%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to GH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 56.39. This target is 28.63% above the current price.
GH was analyzed by 34 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about GH.
In the previous month the buy percentage consensus was at a similar level.
GH was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
GH Historical Analyst RatingsGH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -78 -71 -64 -57 -50 -43 -36 -29 -22 -15 -8 -1 10 20 30

Price Target & Forecast

Price Low Median Mean High 43.8420.2057.1256.3968.25 - -53.92% 30.29% 28.63% 55.68%
GH Current Analyst RatingGH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2025-05-05 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2025-05-01 UBS Maintains Buy -> Buy
2025-05-01 Stifel Maintains Buy -> Buy
2025-05-01 Barclays Maintains Overweight -> Overweight
2025-05-01 TD Securities Maintains Buy -> Buy
2025-05-01 Canaccord Genuity Maintains Buy -> Buy
2025-04-10 Mizuho Initiate Outperform
2025-04-10 Barclays Maintains Overweight -> Overweight
2025-03-26 Stephens & Co. Reiterate Overweight -> Overweight
2025-03-06 Morgan Stanley Maintains Overweight -> Overweight
2025-02-26 Piper Sandler Maintains Overweight -> Overweight
2025-02-24 Guggenheim Reiterate Buy -> Buy
2025-02-24 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2025-02-24 Canaccord Genuity Maintains Buy -> Buy
2025-02-21 Stifel Maintains Buy -> Buy
2025-02-21 Raymond James Reiterate Outperform -> Outperform
2025-02-21 JP Morgan Maintains Overweight -> Overweight
2025-02-21 Goldman Sachs Maintains Buy -> Buy
2025-01-28 Goldman Sachs Maintains Buy -> Buy
2025-01-23 Barclays Initiate Overweight
2025-01-22 Guggenheim Reiterate Buy -> Buy
2024-11-07 JP Morgan Maintains Overweight -> Overweight
2024-11-07 Goldman Sachs Maintains Buy -> Buy
2024-10-30 Bernstein Maintains Outperform -> Outperform
2024-10-17 Leerink Partners Maintains Outperform -> Outperform
2024-08-21 UBS Maintains Buy -> Buy
2024-08-13 Piper Sandler Maintains Overweight -> Overweight
2024-08-08 TD Cowen Maintains Buy -> Buy
2024-08-08 JP Morgan Maintains Overweight -> Overweight
2024-08-08 Craig-Hallum Maintains Buy -> Buy